Patents by Inventor Andreas Missel

Andreas Missel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10793896
    Abstract: The present invention is directed to methods for the generation of nucleic acids from an RNA template and further nucleic acid replication. Specifically, the invention is directed to the generation and amplification of nucleic acids by reverse transcriptase-polymerase chain reaction (RT-PCR).
    Type: Grant
    Filed: August 23, 2017
    Date of Patent: October 6, 2020
    Assignee: QIAGEN GmbH
    Inventors: Nan Fang, Andreas Missel
  • Patent number: 10501783
    Abstract: The present invention relates to methods and uses for the detection or quantification of newly-synthesized double-stranded target nucleic acid molecules in a sample during quantitative real-time polymerase chain reaction (qPCR) amplification. According to the invention, an intercalating dye recognizing double-stranded DNA molecules with higher affinity than single-stranded DNA molecules and a fluorophore-labeled oligonucleotide-probe being sequence specific for a target nucleic acid molecule are simultaneously employed, thus enabling quantification a specific target and total amount of a mixed nucleic acid population, and enabling assessing the cause of suboptimal PCR performance.
    Type: Grant
    Filed: December 9, 2014
    Date of Patent: December 10, 2019
    Assignee: QIAGEN GMBH
    Inventors: Nan Fang, Andreas Missel, Katja Heitz, Holger Wedler
  • Publication number: 20170356026
    Abstract: The present invention is directed to methods for the generation of nucleic acids from an RNA template and further nucleic acid replication. Specifically, the invention is directed to the generation and amplification of nucleic acids by reverse transcriptase-polymerase chain reaction (RT-PCR).
    Type: Application
    Filed: August 23, 2017
    Publication date: December 14, 2017
    Inventors: Nan FANG, Andreas MISSEL
  • Patent number: 9758812
    Abstract: The present invention is in the fields of molecular biology. The present invention is directed to novel compositions, methods and kits useful for the generation of nucleic acids from an RNA template and further nucleic acid replication. Specifically, the invention is directed to the generation and amplification of nucleic acids by reverse transcriptase-polymerase chain reaction.
    Type: Grant
    Filed: August 13, 2012
    Date of Patent: September 12, 2017
    Assignee: Qiagen GmbH
    Inventors: Nan Fang, Andreas Missel
  • Patent number: 9587267
    Abstract: The invention relates to a method for the quantification of one or more nucleic acids in a sample, for example: making a sample available which contains at least one nucleic acid to be quantified, adding an oligonucleotide probe, the oligonucleotide probe comprising a sequence which can specifically hybridize to the nucleic acid to be quantified or to a common sequence of the nucleic acids to be quantified, incubating the sample under conditions which allow the hybridization of the oligonucleotide probe to the nucleic acid(s) to be quantified, incubating the sample under conditions which allow the extension of hybridized probes, the nucleic acid(s) serving as a template in each case, removing the non-hybridized probes from the sample and quantifying the hybridized oligonucleotide probes to measure the quantity of the nucleic acid(s) to be quantified. The invention also relates to a kit for carrying out said method.
    Type: Grant
    Filed: March 9, 2010
    Date of Patent: March 7, 2017
    Assignee: QIAGEN GMBH
    Inventors: Nan Fang, Andreas Missel, Dirk Löffert
  • Publication number: 20160298182
    Abstract: The present invention relates to methods and uses for the detection or quantification of newly-synthesized double-stranded target nucleic acid molecules in a sample during quantitative real-time polymerase chain reaction (qPCR) amplification. According to the invention, an intercalating dye recognizing double-stranded DNA molecules with higher affinity than single-stranded DNA molecules and a fluorophore-labeled oligonucleotide-probe being sequence specific for a target nucleic acid molecule are simultaneously employed, thus enabling quantification a specific target and total amount of a mixed nucleic acid population, and enabling assessing the cause of suboptimal PCR performance.
    Type: Application
    Filed: December 9, 2014
    Publication date: October 13, 2016
    Inventors: Nan Fang, Andreas Missel, Katja Heitz, Holger Wedler
  • Publication number: 20140212884
    Abstract: The present invention is in the fields of molecular biology. The present invention is directed to novel compositions, methods and kits useful for the generation of nucleic acids from an RNA template and further nucleic acid replication. Specifically, the invention is directed to the generation and amplification of nucleic acids by reverse transcriptase-polymerase chain reaction.
    Type: Application
    Filed: August 13, 2012
    Publication date: July 31, 2014
    Applicant: QIAGEN GMBH
    Inventors: Nan Fang, Andreas Missel
  • Publication number: 20140154748
    Abstract: Novel thermostable chimeric nucleic acid polymerases and methods for their generation and use are disclosed. It is shown that these chimeric nucleic acid polymerases, such as DNA polymerases, can be constructed using enzymatically active domains, isolated from different proteins or chemically synthesized. It is demonstrated that chimeric nucleic acid polymerases of the present invention possess the chemical and physical properties of their component domains (e.g., exonuclease activity, thermostability) and that the chimeric polymerases are thermostable.
    Type: Application
    Filed: December 17, 2013
    Publication date: June 5, 2014
    Applicant: QIAGEN GMBH
    Inventors: Dirk Löffert, Andreas Missel, Jie Kang
  • Patent number: 8637288
    Abstract: Novel thermostable chimeric nucleic acid polymerases and methods for their generation and use are disclosed. It is shown that these chimeric nucleic acid polymerases, such as DNA polymerases, can be constructed using enzymatically active domains, isolated from different proteins or chemically synthesized. It is demonstrated that chimeric nucleic acid polymerases of the present invention possess the chemical and physical properties of their component domains (e.g., exonuclease activity, thermostability) and that the chimeric polymerases are thermostable.
    Type: Grant
    Filed: August 8, 2002
    Date of Patent: January 28, 2014
    Assignee: Qiagen, GmbH
    Inventors: Dirk Löffert, Andreas Missel, Jie Kang
  • Publication number: 20120107813
    Abstract: The invention relates to a method for the quantification of one or more nucleic acids in a sample. The method comprises the following steps: making a sample available which contains at least one nucleic acid to be quantified, adding an oligonucleotide probe to the sample, the oligonucleotide probe comprising a sequence which can specifically hybridize to the nucleic acid to be quantified or to a common sequence of the nucleic acids to be quantified, incubating the sample under conditions which allow the hybridization of the oligonucleotide probe to the nucleic acid(s) to be quantified, incubating the sample under conditions which allow the extension of hybridized probes, the nucleic acid(s) serving as a template in each case, removing the non-hybridized probes from the sample and quantifying the hybridized oligonucleotide probes to measure the quantity of the nucleic acid(s) to be quantified. The invention also relates to a kit for carrying out said method.
    Type: Application
    Filed: March 9, 2010
    Publication date: May 3, 2012
    Inventors: Nan Fang, Andreas Missel, Dirk Löffert
  • Patent number: 8129150
    Abstract: The invention relates to composition or a kit containing an enzyme that is reversibly inhibited by means of a chemical modification and an enzyme which is reversibly inhibited using non-covalent binding, the use of a mixture of enzymes reversibly inhibited in such a manner for processing or multiplying polynucleotides, and a method for specifically amplifying DNA by simultaneously using both types of reversibly inhibited enzymes.
    Type: Grant
    Filed: March 30, 2007
    Date of Patent: March 6, 2012
    Assignee: QIAGEN GmbH
    Inventors: Holger Engel, Dirk Löffert, Andreas Missel, Ralf Peist
  • Publication number: 20090117622
    Abstract: The invention relates to composition or a kit containing an enzyme that is reversibly inhibited by means of a chemical modification and an enzyme which is reversibly inhibited using non-covalent binding, the use of a mixture of enzymes reversibly inhibited in such a manner for processing or multiplying polynucleotides, and a method for specifically amplifying DNA by simultaneously using both types of reversibly inhibited enzymes.
    Type: Application
    Filed: March 30, 2007
    Publication date: May 7, 2009
    Applicant: QIAGEN GmbH
    Inventors: Holger Engel, Dirk Loffert, Andreas Missel, Ralf Peist
  • Publication number: 20030138805
    Abstract: Novel thermostable chimeric nucleic acid polymerases and methods for their generation and use are disclosed. It is shown that these chimeric nucleic acid polymerases, such as DNA polymerases, can be constructed using enzymatically active domains, isolated from different proteins or chemically synthesized. It is demonstrated that chimeric nucleic acid polymerases of the present invention possess the chemical and physical properties of their component domains (e.g., exonuclease activity, thermostability) and that the chimeric polymerases are thermostable.
    Type: Application
    Filed: August 8, 2002
    Publication date: July 24, 2003
    Inventors: Dirk Loffert, Andreas Missel, Jie Kang
  • Patent number: 6300069
    Abstract: Novel compositions and methods useful for the generation of nucleic acids from a ribonucleic acid template and further nucleic acid replication are disclosed. It is shown that the generation and amplification of nucleic acids by methods that utilize two or more different polymerases, such as reverse transcriptase-polymerase chain reaction (RT-PCR), are dramatically more sensitive and efficient in the presence of a homopolymeric nucleic acid. Homopolymeric nucleic acids have been found to reduce or negate the inhibitory effect reverse transcriptases have on DNA polymerase activity. It is demonstrated that this inhibition-relieving effect of homopolymeric nucleic acids is general in nature; independent of the chemical species of homopolymer used, or the chemical composition of the polymerization reaction mixture.
    Type: Grant
    Filed: May 3, 1999
    Date of Patent: October 9, 2001
    Assignee: Qiagen GmbH
    Inventors: Andreas Missel, Dirk Löffert, Jie Kang, Christian Korfhage